STAT The RECOVER Initiative offers an historic opportunity to transform post-viral illness research. The National Institutes of Health is at a crossroads with the RECOVER Initiative, its flagship program to address long Covid. Designed to provide answers and treatments for the millions suffering from long-term effects of SARS-CoV-2 infection, the initiative has already received significant criticism for failing to prioritize the needs of patients and advance meaningful clinical trials. Now, as Congress, the scientific community, and advocates call for the inclusion of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) within the RECOVER framework, NIH has an historic opportunity to transform post-viral illness research.
NIH must address the twin crises of long Covid and ME/CFS — together
- Published Feb 5, 2025